In addition to President Trump’s April executive order to cap prices at $35 a month for Medicare Part D enrollees, Lilly also offers a $35 insulin program, and Novo Nordisk offers multiple discounts, including a $25 vial offer redeemable at Walmart under the name ReliOn. However, for privately insured diabetes patients, copay caps vary by state and eligibility. For example, there is a $100 copay cap for diabetes patients in Vermont, but in New York, there is $0 cost sharing. As a result, type 1 diabetes patients rely on insulin indefinitely. Diabetes patients incurred an average of $19,736 annually in health expenses, with $12,022 attributable to diabetes.